In situ macrophage phenotypic transition is affected by altered cellular composition prior to acute sterile muscle injury by Patsalos, Andreas et al.
1		
In situ macrophage phenotypic transition is affected by altered cellular 
composition prior to acute sterile muscle injury 
 
Andreas Patsalos1, Attila Pap1, Tamas Varga1, Gyorgy Trencsenyi4, Gerardo Alvarado 
Contreras5, Ildiko Garai4, Zoltan Papp5, Balazs Dezso 6, Eva Pintye3, Laszlo Nagy1,2,7. 
 
(1) Department of Biochemistry and Molecular Biology, University of Debrecen, 
Debrecen H-4032, Hungary,  
(2) MTA-DE “Lendület” Immunogenomics Research Group, University of 
Debrecen, Debrecen, Hungary,  
(3) Department of Radiotherapy, Institute of Oncology, University of Debrecen, 
Debrecen, Hungary,  
(4) Scanomed LTD, Debrecen, Hungary,  
(5) Division of Clinical Physiology, Institute of Cardiology, Faculty of Medicine, 
University of Debrecen, Debrecen, Hungary,  
(6) Department of Pathology, Faculty of Medicine, University of Debrecen, 
Debrecen, Hungary. 
(7) Sanford-Burnham-Prebys Medical Discovery Institute at Lake Nona, Orlando, 
FL, USA.  
2		
Key points 
 
• The in situ phenotypic switch of macrophages is delayed in acute injury 
following irradiation. 
• The combination of bone marrow transplantation along with local muscle 
radiation protection, allows for the identification of myeloid cell contribution to 
tissue repair.  
• PET-MRI allows monitoring myeloid cell invasion and metabolism. 
• Altered cellular composition prior to acute sterile injury affects the in situ 
phenotypic transition of invading myeloid cells to repair macrophages. 
• There is reciprocal intercellular communication between local muscle cell 
compartments, such as PAX7 positive cells and recruited macrophages during 
skeletal muscle regeneration. 
 
Abstract 
 
Skeletal muscle regeneration is a complex interplay between various cell types 
including invading macrophages. Their recruitment to damaged tissues upon acute 
sterile injuries is necessary for necrotic debris clearance and for coordination of tissue 
regeneration. This highly dynamic process is characterized by an in-situ transition of 
infiltrating monocytes from an inflammatory (Ly6Chigh) to a repair (Ly6Clow) 
macrophage phenotype. The importance of the macrophage phenotypic shift and the 
cross-talk of the local muscle tissue with the infiltrating macrophages during tissue 
regeneration upon injury are not fully understood and their study lacks adequate 
methodology. Here, using an acute sterile skeletal muscle injury model combined with 
irradiation, bone marrow transplantation and in vivo imaging we show that preserved 
muscle integrity and cell composition prior to the injury is necessary for repair 
macrophage phenotypic transition and subsequently for proper and complete tissue 
regeneration. Importantly, by using a model of in vivo ablation of PAX7 positive cells, 
we show that this radiosensitive skeletal muscle progenitor pool contributes to 
macrophage phenotypic transition following acute sterile muscle injury. In addition, 
local muscle tissue radioprotection by lead shielding during irradiation preserves normal 
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macrophage transition dynamics and subsequently muscle tissue regeneration. Taken 
together, our data suggest the existence of a more extensive and reciprocal cross-talk 
between muscle tissue compartments, including satellite cells, and infiltrating myeloid 
cells upon tissue damage. These interactions are shaping the macrophages in-situ 
phenotypic shift, which is indispensable for normal muscle tissue repair dynamics. 
 
Abstract Figure Legend 
 
Myeloid cells play an essential role in skeletal muscle regeneration following acute 
sterile injury. However, by carrying out BMT we observe delayed muscle regeneration 
after injury. Radioprotection by lead shielding protects the muscles of mice during 
gamma irradiation, by preserving the local resident pool of satellite cells that are 
important for efficient regeneration. The survival of satellite cells and other local 
populations affects macrophage transition from inflammatory (Ly6Chigh F4/80low) to 
repair (Ly6Clow F4/80high) phenotype, which is critical for normal muscle tissue repair 
dynamics. 
 
Abbreviations 
 
Ly6C, lymphocyte antigen 6 complex, locus C; BMT, bone marrow transplantation; 
FAP, fibro/adipogenic progenitors; CTX, cardiotoxin; TA, Tibialis anterior; PET, 
Positron Emission Tomography; MRI, Magnetic Resonance Imaging; PAX7, Paired 
Box 7. 
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Introduction 
 
The maintenance of skeletal muscle mass and metabolic capacity is critical for 
human health and quality of life (Wolfe RR 2006). Skeletal muscle has distinct 
metabolic and contractile properties that are influenced by nutrient uptake, 
microenvironment, and physical activity. Age, disuse, fasting, and various degenerative 
diseases alter skeletal muscle mass and function (García-Prat L, et al. 2016, Walston JD. 
2012, Goljanek-Whysall K et al. 2016). Additionally, a growing number of elderly and 
cancer patients continue to receive radiation therapy (Zachariah B. et al. 1997, Peault 
Bruno RM. et al. 2007) even though it has been proposed that radiation is the main 
cause leading to muscular fatigue and weakness as observed following treatment 
(Giacalone A. et al. 2013). However, skeletal muscle has the remarkable ability to 
regenerate, which it does not only in response to direct trauma but also under normal 
physiological conditions. Thus, efforts to understand the side effects of radiation on 
various skeletal muscle tissue compartments are necessary to improve both the 
treatments and the outcomes during radiation therapy and particularly under states of 
reduced or limited regenerative capacity. Skeletal muscle regeneration is a collection of 
highly synchronized processes involving several cellular, molecular and signaling 
responses. Coordinating inflammation and regeneration is particularly important for 
efficient repair (ad integrum) following acute injury (Bentzinger CF. et al. 2013).  
A chief reason for the lack of better understanding of muscle repair is that 
skeletal muscle tissue comprises of many different cell types, such as satellite cells, 
fibroblasts, fibro/adipogenic progenitors (FAPs), endothelial and periendothelial cells, 
mast cells, macrophages (resident and patrolling circulatory monocytes) and T cells, 
that all can affect the myofiber environment (reviewed in Bentzinger CF. et al. 2013). 
Any disturbance of these cell’s interactions could disrupt tissue homeostasis and 
consequently repair. Satellite cells are known to be key regulators of the skeletal muscle 
compartment (Murphy et al. 2011, Lepper et al. 2011, Sambasivan et al. 2011). These 
cells are undifferentiated myogenic cells that are found between the sarcolemma 
and basal lamina, and can fuse to establish new myofibers (Hawke TJ, et al. 2001). 
These quiescent cells mature into postmitotic myofibers through specific extracellular 
signals. Initially these paracrine or autocrine signals result in myoblast expansion 
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followed by pro-differentiation signals that are required to induce their maturation. The 
exact nature of such signals is still not clearly defined. Many candidate molecules have 
been proposed to mediate myoblast differentiation such as IL-6 (Serrano et al. 2008), 
insulin growth factors (Tonkin J et al 2015), and more recently growth differentiation 
factors (Varga et al 2016 (B)), supporting the notion that a range of factors are involved 
in this differentiation process. Furthermore, only recently we started to understand 
which cell types (FAPs, and macrophages) are responsible for producing these factors 
(Joe A.W. et al. 2010, Arnold et al. 2007). In the context of muscle regeneration 
following acute sterile injury, the satellite cells interact primarily with inflammatory and 
stromal cells i.e. fibroblasts, pericytes, and FAPs (Bentzinger CF. et al. 2013). 
Importantly, it has been suggested that the cross talk between these tissue compartments 
is crucial both in regulating myoblast expansion and differentiation but also regarding 
the outcome of skeletal muscle regeneration. One approach to study such processes is to 
selectively eliminate a particular cellular component. 
Previous studies (1) examining the necessity of satellite cells in muscle 
hypertrophy (Adams et al., 2002; Phelan and Gonyea, 1997; Rosenblatt and Parry, 
1992; Rosenblatt and Parry, 1993; Rosenblatt et al., 1994), (2) testing the effect of the 
host satellite cell niche on donor satellite cell engraftment (Boldrin, L. et al. 2012), (3) 
exacerbating the mdx muscle pathology (Wakeford et al. 1991), used γ-irradiation as a 
method to ablate satellite cells. Thus, the current understanding is that irradiation can 
cause a reduction in satellite cell numbers (Olive Montserrat BR et al. 1995), which 
impairs the structure (Darden EB, Jr 1960, Bergstrom RM et al. 1962) and regeneration 
capacity of the irradiated muscle (Wakeford et al. 1991, Jurdana et al. 2013). However, 
it is not known how crosstalk between satellite cells and other tissue compartments 
contribute to synchronized repair. At the same time, the field lacks adequate 
methodology to study and thoroughly delineate the exact nature of such interactions. 
A particularly interesting and important aspect of regeneration is the invasion 
and conversion of circulating inflammatory monocytes into inflammatory macrophages 
(MFs) and then conversion into repair type ones (Arnold et al. 2007, Varga et al 2016 
(A)). Acute muscle injury causes the recruitment of monocytes/macrophages into the 
damaged area of the muscle and this invasion peaks within the first two days after the 
injury (Tidball 2005). In the absence of macrophages, muscle regeneration is severely 
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impaired (Arnold et al. 2007, Tidball and Wehling-Henricks 2007, Mirza et al. 2009, 
Wang et al. 2014), highlighting the importance of these cells in the regeneration 
process.  The roles of these immune cells in response to the injury are (1) to confine the 
damage, (2) clear the necrotic debris through phagocytosis and (3) repair the damage. 
There are multiple lines of evidence to suggest that macrophages instruct satellite cells 
to proliferate and differentiate, by secreting cytokines, growth factors and other 
molecules that regulate the satellite cell pool (Tidball et al. 2010, Mounier et al. 2013, 
Saclier M. et al. 2013, Tonkin J et al 2015), including our recent findings that 
macrophage secreted growth and differentiation factor 3 (GDF3) contributes to 
myoblast fusion (Varga et al 2016 (B)). This highly dynamic process is characterized by 
an in-situ transition of infiltrating monocytes from an inflammatory (Ly6Chigh) to a 
repair (Ly6Clow) macrophage phenotype (Varga et al. 2013), which appears to be 
indispensible for proper regeneration (Wang et al. 2014).  It is likely that the 
microenvironment is driving the inflammatory to repair phenotypic switch, however, it 
still remains to be determined how macrophages make this in situ phenotypic shift. 
Thus, we hypothesized that there is likely to be a reciprocal communication between 
local muscle cell populations and macrophages and not only macrophages instructing 
these cells but vice versa. For example, the presence and signals from the satellite cells 
might be required for the invasion and phenotypic shift of macrophages, which is 
crucial for the outcome of muscle regeneration. 
Here, by using the cardiotoxin (CTX) induced skeletal muscle injury, as an 
established and highly reproducible in vivo model of acute muscle injury and sterile 
physiological inflammation (Hardy D., et al 2016) combined with (1) irradiation as a 
means to alter cellular composition prior to injury, (2) bone marrow transplantation with 
an extended (3 months) recovery period to replenish myeloid cells, (3) in vivo imaging 
to monitor the myeloid cell phenotypic switch in situ, and (4) focusing on in vivo 
ablation of a specific muscle cell population (paired box 7 (PAX7) positive cells) as a 
proof of concept, we show that muscle tissue integrity and cell composition prior to the 
injury is required for in situ macrophage phenotypic shift and subsequently for proper 
and complete tissue regeneration. Taken together, our data reveal the existence of a 
reciprocal cross talk between the skeletal muscle tissue and myeloid cells recruited 
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following the injury and establish an experimental paradigm suitable to dissect the 
components of immune cell invasion assisted tissue repair. 
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Materials and Methods 
 
Ethical approval:  
All animal experiments were carried out in accordance with guidelines prescribed by 
the Institutional Animal Care and Use Committee at Sanford Burnham Prebys Medical 
Discovery Institute and University of Debrecen, School of Medicine following 
Hungarian (license no.: 21/2011/DEMÁB) and European regulations. 
 
Mice:  
Wild type BoyJ (B6.SJL-Ptprca Pepcb /BoyJ, stock number 002014) and C57BL/6J male 
control mice were obtained from the Jackson Laboratories and bred under specific-
pathogen free (SPF) conditions. Experiments were conducted on adult (2-6 month old) 
male mice. All irradiation experiments were performed under anaesthesia in cohorts of 
12 animals per experiment. Briefly, mice were anaesthetized with a single 
intraperitoneal dose of ketamine/xylazine (ketamine 80-100 mg/kg, xylazine 10-12.5 
mg/kg). Irradiated and bone marrow transplanted mice were maintained in an SPF status 
(autoclaved top filter cages) for the entire course of experimentation and antibiotics 
(amoxicillin antibiotic, clavulanic acid [500mg/ 125 mg/ liter of drinking water]) were 
administered in the drinking water for 4 weeks after transplantation to minimize 
bacterial contamination within the water source and potentially decrease the burden of 
gastrointestinal bacteria. Irradiated mice were also fed autoclaved rodent chow ad 
libitum. Animals that undergo irradiation for BMT typically lose a considerable amount 
of weight, only to gain it back relatively quickly after successful transplantation. At our 
institutions, weight loss of 20%, or greater was used as a rationale for euthanasia before 
the intended experimental endpoint according to the IACUC guidelines. 
The Pax7CreER/+, Rosa26DTA/+ strain, designated Pax7-DTA, was generated by 
crossing Pax7CreER/CreER and Rosa26DTA/DTA strains. Pax7-DTA pups were genotyped by 
PCR are as previously described (Nishijo et al. 2009; Wu et al. 2006). The tamoxifen-
treated mice were kindly provided by Dr. John McCarthy and Dr. Charlotte Peterson. 
When necessary and for tissue collection mice were euthanized by either isoflurane 
overdose (adjusted flow rate or concentration to 5% or greater) or CO2 exposure 
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(adjusted flow rate 3 L/min) in accordance to the University of Debrecen and Sanford 
Burnham Prebys Medical Discovery Institute’s IACUC guidelines. 
Bone Marrow Transplantation (BMT): 
Recipient congenic BoyJ mice (7 weeks old) are irradiated with 9.5 or 11 Gy using a 
Theratron 780C cobalt unit for the ablation of the recipient bone marrow. The animals 
to be irradiated were immobilized using a circular cage (mouse pie cage) that can hold 
up to 11 mice  (alert mice). Following the irradiation, isolated bone marrow cells (in 
sterile RPMI-1640 medium) flushed out the femur; tibia and humerus from donor 
C57BL/6J mice are transplanted into the recipient mice by retro-orbital injection 
(20x106 BM cells per mice). This experimental BMT CD45 congenic model allows us 
to detect donor, competitor and host contribution in hematopoiesis and repopulation 
efficiency of donor cells (congenic mice with CD45.1 versus CD45.2). The CD45.1 and 
CD45.2 contribution is then detected by flow cytometry usually 8-12 weeks following 
the BMT. In short a cut at the tail tip of the mice provided a drop of blood that was 
placed into 0.5 ml PBS + 1% FBS + 10 U/ml Heparin buffer (samples kept on ice). The 
cells were directly stained by 2 µl mouse anti-mouse CD45.2-FITC (clone 104) and 2 µl 
rat anti-mouse   GR1-PE (clone RB6-8C5) antibodies (BD Pharmingen) and incubated 
on ice for 30 min. After 2 washes with ice-cold PBS/FBS/Heparin buffer we 
resuspended the cells in 0.5-1 ml FACS Lysing solution (BD Cat #349202). We 
incubated for 5 min at RT then centrifuged the cells (400g, 5 min, 4°C).  We run the 
double stained samples on FACS (BD FACS Calibur) and determined the ratio of donor 
cells. The repopulation is usually over 90% gated on the granulocyte fraction.  
 
Bone Marrow Transplantation (BMT) including local radioprotection:  
An adaptation of the above protocol was used that includes hindlimb lead shielding. The 
animals to be irradiated were anesthetized via intraperitoneal injection of ketamine (80 
mg/kg) and xylazine (10 mg/kg), and placed into a plastic box, with double wall. Water 
was between the walls, for scattering medium, in order to get homogeneous dose 
distribution. Two 5 cm high led blocks were used for protection one of the legs of the 
mouse. The blocks were on the PMMA shadow tray of the cobalt unit, more than 20 cm 
distance to the surface of the plastic box, so the air absorbs the Compton electrons from 
the blocks. The top plate of the box has 5 mm thickness that is the buildup region for 
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cobalt energy. The source surface distance (SSD) and source axis distance (SAD) was 
80 cm. The beam size is 21x21 cm. The activity of the 60Co isotope was about 50 TBq 
(1350 Ci). Animals are generally irradiated for short periods of time depending on the 
radioisotope decay charts, amount of irradiation needed, and source of ionizing energy. 
In our case the time of irradiation was about 20-30 min (as a function of the given date). 
Following the irradiation, isolated bone marrow cells from donor C57BL/6J mice are 
transplanted into the recipient mice by retro-orbital injection. 
 
Lower body irradiation:  
As described above, 5cm thick lead shielding blocks were used during irradiation, to 
protect one of the back legs of lightly sedated mice with the exception that this time we 
focused the radiation field (14.4 cm x 4.8 cm) only in the lower part of their bodies just 
below the hip thus minimizing radiation exposure to the rest of the body. The source 
surface distance (SSD) and source axis distance (SAD) was kept the same and mice 
were irradiated with a dose of 11 Gy. The animals left to recover for 8 weeks after the 
radiation exposure. 
 
Muscle injury:  
Mice were anaesthetized with isoflurane (adjusted flow rate or concentration to 1,5%)  
and 50 µl of cardiotoxin (12X10-6 M in PBS) (from Latoxan) was injected in the tibialis 
anterior (TA) muscle. Muscles were recovered for flow cytometry analysis at day 1 to 
day 8 post-injury or for muscle histology at day 8 to day 20 post-injury.  
 
Histological analysis of muscle regeneration:  
Muscles were removed and snap frozen in nitrogen-chilled isopentane (–160°C). 8 µm 
thick cryosections were cut and stained with hematoxylin-eosin (H&E). For each 
histological analysis, at least 5 slides (per condition) were selected where the total 
regenerative region within the CTX injured TA muscle was at least 70%.  For each TA, 
myofibers in the entire injured area were counted and measured. H&E muscle sections 
were scanned with Mirax digital slide scanner and the Cross Sectional Area (CSA) was 
measured with HALO software (Indica Labs). CSAs for these samples are reported in 
µm2. Quantitative analysis of necrotic/phagocytic vs. centrally nucleated myofibers was 
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performed using the Panoramic Viewer software and was expressed as a percentage of 
the total number of myofibers. Necrotic/phagocyted myofibers were defined as pink 
pale patchy fibers that are invaded by basophil single cells (macrophages). 
 
Immunohistochemistry (Frozen sections):  
Tissue sections were fixed and permeabilized in ice cold acetone for 5 min and blocked 
for 30 minutes at 20 °C (room temperature) in PBS containing 2 % bovine serum 
albumin (BSA). Tissues were stained for 1 h at room temperature using a primary 
antibody diluted in 2 % BSA. The primary antibodies used for immunofluorescence 
were rabbit anti-laminin (L9393 SIGMA) at a dilution 1/200, chicken anti-PAX7 
(DSHB) at a dilution 1/20, rabbit anti-Desmin (Abcam 32362) at a dilution 1/200 and 
rat anti-F4/80 (Abcam 6640) at a dilution 1/200. In all cases, the primary antibody was 
detected using secondary antibodies (dilution 1/200) conjugated to FITC (JIR 703-095-
155) or Cy3 JIR (711-165-152). The nuclei were counter stained with 0.1-1 µg/ml 
Hoechst. Fluorescent microscopy was performed using Carl Zeiss Axio Imager Z2 
microscope equipped with lasers at 488, 568 and 633 nm. Figures were analyzed and 
assembled using Fiji and Illustrator CS5 (Adobe). 
  
Isolation of macrophages from muscle:  
Fascia of the TA was removed. Muscles were dissociated in RPMI containing 0.2% 
collagenase B (Roche Diagnostics GmbH) at 37°C for 1 hour and filtered through a 100 
µm and a 40 µm filter. CD45+ cells were isolated using magnetic sorting (Miltenyi 
Biotec). For FACS, macrophages were treated with Fcγ receptor blocking antibodies 
and with 10% normal rat serum: normal mouse serum 1:1 mix, then stained with a 
combination of PE-conjugated anti-Ly6C antibody (HK1.4, eBioscience), APC-
conjugated F4/80 antibody (BM8, eBioscience) and FITC-conjugated Ly6G antibody 
(1A8, Biolegend). Ly6Chigh F4/80low macrophages, Ly6Clow F4/80high macrophages and 
Ly6Ghigh Ly6Cmed F4/80- neutrophils were quantified. In each experiment, compared 
samples were processed in parallel to minimize experimental variation. Cells were 
analyzed on a BD FACSAria III sorter and data analysis was performed using BD 
FACSDIVA and FlowJo V10 software.  
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RNA isolation:  
Total RNA was isolated with TRIZOL reagent according to the manufacturer’s 
recommendation. 20ug glycogen (Ambion) was added as carrier for RNA precipitation.  
 
RT-qPCR:  
Transcript quantification was performed by quantitative real-time RT (reverse 
transcriptase) PCR (polymerase chain reaction) using SYBR Green assays.  
Primer sequences used in transcript quantification are as follows: 
Pax7 forward 5’-ggcacagaggaccaagctc-3’, PAX7 reverse 5’-gcacgccggttactgaac-3’, RT-
qPCR results were analyzed with the standard delta Ct method and results were 
normalized to the expression of Rps26. 
 
Small animal PET-MRI imaging using 18F-FDG:  
During the light cycle to minimize muscle activity, C57BL/6 or BoyJ mice were 
injected with 8.0±0.2 MBq of 18F-FDG via the lateral tail vein in 0.2 mL volume. 50 
min after 18F-FDG injection animals were anaesthetized by 3% isoflurane with a 
dedicated small animal anesthesia device and whole body PET scans (10-min static PET 
scans) were acquired using the preclinical nanoScan PET/MRI system (Mediso Ltd., 
Hungary). To prevent movement, the animals were fixed to a mouse chamber 
(MultiCell Imaging Chamber, Mediso Ltd., Hungary) and positioned in the center of 
field of view (FOV). For the determination of the anatomical localization of the organs 
and tissues, T1-weighted MRI scans were performed (3D GRE EXT multi-FOV; TR/TE 
15/2 ms; FOV 70 mm; NEX 2). PET volumes were reconstructed using a three-
dimensional Ordered Subsets Expectation Maximization (3D-OSEM) algorithm (Tera-
Tomo, Mediso Ltd., Hungary). PET and MRI video and images were automatically co-
registered by the PET/MRI instrument’s acquisition software (Nucline). Reconstructed, 
reoriented and co-registered images were further analyzed with InterView™ FUSION 
(MedisoLtd., Hungary) dedicated image analysis software. 
 
PET data analysis:  
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Radiotracer uptake was expressed in terms of standardized uptake values (SUVs). 
Ellipsoidal 3-dimensional Volumes of Interest (VOI) were manually drawn around the 
edge of the TA and GAST muscles activity by visual inspection using InterView™ 
FUSION multi-modal visualization and evaluation software (Mediso Ltd., Hungary). 
The standardized uptake value (SUV) was calculated as follows: SUV = [VOI activity 
(Bq/mL)]/[injected activity (Bq)/animal weight (g)], assuming a density of 1 g/mL 
 
Ex vivo radiotracer uptake studies:  
Cells were isolated from injured muscles as described above. Live cells for both 
myeloid CD45+ and non-myeloid CD45- fractions were selected using FACS-sorting 
based on FSC/SSC gating and then washed and resuspended in PBS containing 1 mM 
glucose. The samples were pre-incubated at 36 °C for 10 min at a cell concentration of 
1 × 106 /ml in PBS and 0.37 MBq/ml 18F-FDG was then added to each sample. After the 
addition of the radioligand, cells were further incubated at 36 °C for 50 min and the 
uptake was terminated by the addition of ice-cold PBS. The cells were then washed 
three times with cold PBS and resuspended in 1 ml of cold PBS, and the radioactivity 
was measured. The tubes were measured in a Canberra Packard gamma-counter for 1 
min within the 18F-sensitive energy window. Decay-corrected radiotracer uptake was 
expressed as counts min−1 (106 cells)−1 (cpm). The displayed data are the means ± SD of 
the results of at least three independent experiments, each performed in triplicate. 
 
Expression data processing and analysis:  
GSE71155 data sets were loaded into the Genespring GX software, and multiarray 
average summarization was carried out. Next, the lowest 5% of the entities with 
detectable signals were ﬁltered out as not expressed. Duplicate entities, not/poorly 
annotated transcripts and transcripts reporting inconsistent expression values were also 
discarded. Further analysis was carried out on the ﬁltered data set based on the RAW 
expression values. Heatmap was generated based on log10-transformed raw values with 
R software package pheatmap. Hierarchical clustering analysis was then applied by 
Euclidean distance measure and Ward’s clustering algorithm, to ﬁnd correlated genes. 
 
Statistics:  
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All experiments were performed using at least four biological replicates. Student’s t-
tests and 2-way ANOVA analyses were performed in GraphPad Prism 6 and P<0.05 
was considered significant (P<0.05=*, P<0.01=**, P<0.001=***, P<0.0001=****). 
Mean and SEM values are shown in graphs. 
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Results 
 
Cardiotoxin induced skeletal muscle damage is a robust model of immune cell 
assisted regeneration.  
 
We sought to understand the role and contribution of myeloid cells, primarily 
macrophages and also their interactions during skeletal muscle regeneration. We chose 
the CTX induced skeletal muscle injury model since this model proved to be 
instrumental for the identification of exogenous mechanisms of muscle regeneration 
(Chazaud B 2014, Varga T et al. 2016 (A), Varga T et al. 2016 (B)) but it is also 
suitable to study the effect of the regenerating muscle upon myeloid cell activity. The 
model works as follows:  by injecting cardiotoxin (snake venom peptide that acts as 
protein kinase C-specific inhibitor) intramuscularly, we induced homogenous skeletal 
muscle damage in the Tibialis anterior (TA) muscles. In more than ten independent 
experiments, identical morphological changes were observed. Histological analysis by 
hematoxylin and eosin (H&E) staining demonstrated global myofiber destruction and 
edema at days 1 and 2 post injury (Figure 1A). By day 8 after the injury the overall 
architecture of the muscle is restored although most regenerated myofibers are smaller 
and display central myonuclei, a known hallmark of recent muscle regeneration (Figure 
1A). Thus any change in the cellular composition or altered histological features at day 
8 post injury, indicates perturbations in intracellular communications. 
 Upon CTX injury a large number of circulating immune cells infiltrate and 
accumulate in a rapid and highly ordered manner inside the injured tissue. This pool of 
invading cells consists primarily of neutrophils, monocytes and macrophages. More 
specifically, after acute injury Ly6Chigh F4/80low monocytes infiltrate early at day 1 to 
promote the clearance of necrotic debris, whereas Ly6Clow F4/80high macrophages 
emerge later through a phenotypic shift (Varga et al. 2013) starting at day 2 and 
completed by day 4, to assist tissue healing (Figures 1B-C). To complement these 
results, F4/80high expressing macrophage’s localization was assessed using 
immunohistochemistry from injured muscles at Day 4 and 8 after CTX (Figure 1D). 
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Furthermore, it was shown that Ly6Chigh macrophages express tumour necrosis factor α 
(TNFα) and interleukin (IL)-1β at higher levels and transforming growth factor β (TGF-
β) and IL-10 at lower levels compared to Ly6Clow macrophages (Perdiguero et al 2011, 
Wang et al., 2014). Therefore, they were considered as pro-inﬂammatory and anti-
inﬂammatory macrophages, respectively. However, we recently reported (Varga et al. 
2016 (A)) that Gr1+ and Gr1- muscle derived macrophages do not display, in general, 
high differential expression levels of pro-inﬂammatory (M1) or anti-inﬂammatory (M2) 
markers. In line with our previous report, re-analyzing more recent publicly available 
data sets (Varga et al. 2016 (A)), that was obtained using our FACS gating strategy 
(Figure 1B), and by performing hierarchical clustering on a large number of known 
macrophage marker genes, we report expression patterns with modest differences 
(Figure 1E). Out of 69 markers we looked at, only 14 followed the expected pattern 
based on the M1/M2 axes, among them CD80, CD86, Nlrp3, Ccr2, Irf4, Emr1, Igf1, 
Pparg, Clec10a. In addition, the repair macrophages (Ly6Clow) exhibited minimal 
expression of the well-established M2 marker CD163, which is in agreement with 
recent studies (Wang et al. 2014), while others such as MRC1 and CD68 where highly 
expressed but remained unchanged between the different muscle macrophage subtypes. 
These results show that Ly6Chigh and Ly6Clow macrophages in regenerating muscle 
display distinct inﬂammatory proﬁles than those described in the literature in vitro or 
from the M1/M2 macrophage subtype classification and thus cannot be deﬁned as 
canonical M1 or M2 macrophages. These findings support the notion that surface 
markers for macrophage subsets vary depending on the injury model and tissue they are 
extracted from.  
However, the importance and regulation of the phenotypic shift to repair 
macrophages, as well as the influence of the local muscle environment, including the 
satellite cell pool, prior to an acute insult on these, are not known. Therefore we decided 
to look at the influence of satellite cell depletion on this process. 
 
The satellite cell pool is radiation sensitive and is required for proper muscle 
regeneration. 
 
We first sought to validate whether muscle regeneration is indeed impaired in 
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irradiated muscles (Wakeford et al. 1991), and second whether this effect is due to 
diminished satellite cell populations (Barton-Davis ER et al. 1999, Caiozzo VJ et al. 
2010). The radiation dose we chose was 11 Gy because it has been reported that 
C57BL/6J mice can tolerate radiation doses of 10 to 11 Gy (Duran-Struuck R et al. 
2008). We used a method, which we termed lower body irradiation where mouse 
hindlimbs were irradiated and left to recover for 8 weeks after the radiation exposure 
(for details see methods). For this method non-irradiated and radioprotected (irradiated 
but simultaneously lead shielded) muscles served as control. Please note that the 
irradiated and radioprotected control belong to the same animal. TA muscles were then 
injured with CTX, and analyzed 8 days later using histology and morphometry. 
Importantly, muscle regeneration in the irradiated muscles is severely impaired, even 
after 2 months post irradiation, in comparison to control non-irradiated or 
radioprotected muscles as shown by histological analysis (Figure 2A). This impairment 
can also be illustrated by a significant shift to the left of the distribution of the myofiber 
Cross Sectional Area (Figure 2B), a decrease in the mean CSA of regenerating 
myofibers (-46%, p < 0.0001), (Figure 2B right panel) and a dramatic increase in 
necrotic fibers (Figure 2C). Macroscopically one can observe more than 35% reduction 
in the mass of the irradiated muscles compare to the contralateral radioprotected 
muscles of the same animals and also compared to age and weight matched non-
irradiated control animals of the same genetic background (Figure 3A). The fact that 
we observe differences even after 2 months post irradiation is an important feature of 
the experimental setup because in this way one can avoid any short-term effects of 
irradiation induced toxicity. 
To assess the effect of irradiation on the local muscle cell pool and more 
specifically on satellite cell pool, we measured the mRNA expression of a commonly 
used marker; Pax7 (von Maltzahn J., et al 2013), via qPCR and validated PAX7 through 
immunohistochemistry. Our data show that indeed Pax7 (Figure 2D) mRNA expression 
is decreased in the irradiated muscles compared to controls and radioprotected muscles 
at 8 weeks following irradiation. Interestingly, this effect is evident in both injured (Day 
8 post CTX) and uninjured irradiated muscles (Day 0). Furthermore, PAX7 staining 
revealed fewer PAX7+ cells in the irradiated muscles (Figure 2E) both at day 0 
(Figures 2E and 2F) and day 8 post CTX injury (Figures 2E and 2G). Radioprotected 
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muscles served as control and showed similar numbers of PAX7+ cells to non-irradiated 
control muscles. These results suggest that PAX7+ satellite cells are indeed 
radiosensitive and are likely to be the major cause of the muscle regeneration deficiency 
observed in irradiated muscles. 
 
Delayed phenotypic transition of myeloid cells in irradiated muscles following 
CTX injury. 
 
Next, we asked whether the impaired muscle integrity, and the altered cellular 
composition induced by irradiation prior to an acute injury, would have any effect on 
the cellular dynamics of the myeloid cell infiltrate during muscle regeneration (even 
after 2 months post irradiation). Hence, we injected both TA muscles of irradiated mice 
with CTX and the myeloid cells were isolated at Day 4 and 6 after the injury using 
CD45+ magnetic bead selection. Interestingly, we found a statistically significant 
increase in the numbers of invading myeloid cells (CD45+) in the irradiated versus 
radioprotected muscles at both timepoints (Figure 3B), thus excluding the possibility of 
a massively diminished myeloid cell invasion contributing to the muscle regeneration 
impairment we observed in Figure 2A.  
However, this finding did not exclude the possibility of a change in the cellular 
composition and differentiation of the infiltrating myeloid cells. Therefore, we 
examined the dynamics of the infiltrating myeloid cell populations during the course of 
the regeneration period in irradiated and radioprotected muscles (Figure 3C). At day 4 
post CTX, the ratio of Ly6Chigh F4/80low and Ly6Clow F4/80high macrophages in injured 
muscle between irradiated versus non-radiated or radioprotected controls show 
remarkable differences (Figures 3C-D).  Normally, in an uncompromised tissue, by day 
4 after CTX injury, Ly6Chigh inflammatory macrophages are progressively 
differentiating into Ly6Clow repair macrophages (Figure 1B). This is the case for non-
irradiated and radioprotected controls (Figure 3C-D). Surprisingly, in the case of 
irradiated muscles, this shift starts later and is completed only by day 6 (Figures 3C-E). 
In summary, we observe a remarkably long 2-day delay (in the context of an 8 day 
regeneration process) in the phenotypic transition of infiltrating myeloid cells in the 
irradiated muscles. In addition, it also showed that radioprotection (in the form of lead 
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shielding) during irradiation exposure prevented the delay of muscle regeneration 
following CTX injury, by preserving the local muscle cell composition and by 
maintaining the infiltrating myeloid cell kinetics. However, we reached the limit of this 
method because we are unable to differentiate between the BM-derived and the tissue 
resident macrophages as the source of the infiltration.  
 
Bone marrow transplantation allows establishing the source of myeloid cell 
invasion and phenotypic shift.  
 
In order to control the source of the infiltrating cells (BM-derived), and to 
exclude the possibility that the restoration of the infiltration dynamics in the 
radioprotected muscles is due to the protection of the resident tissue macrophages, we 
performed bone marrow transplantation (BMT). This method allowed us to investigate 
whether the infiltrating myeloid cells in both the radioprotected and irradiated muscles 
share the same features, and originate from the donor C57BL/6J bone marrow (CD45.2 
positive). We used C57BL/6 congenic mice (BoyJ) which carry a differential CD45 pan 
leukocyte marker (CD45.1), compared to WT C57BL/6J inbred mice that express the 
CD45.2 allele allowing discrimination between donor and recipient BM-derived cells. 
After a radiation dose of 11 Gy, animals were transplanted with C57BL/6J bone 
marrows (BM) and left to recover for 8 weeks after the BMT. It is important to note that 
total body irradiation precedes BMT thus giving us the unique opportunity to combine 
irradiation induced cell ablation and myeloid cell tracing. TA muscles were then injured 
with CTX, and analyzed 8 days later using histology and morphometry. 
Macroscopically we can observe almost a 48% reduction in the mass of the muscles 
compare to age and weight matched non-BMT control animals of the same genetic 
background (Figures 4A-B). Thus, in agreement with our previous lower body 
irradiation experiments (Figure 2A), muscle regeneration in these BMT animals is 
severely impaired, even after 2 months post irradiation and BMT, in comparison to 
control non-BMT animals (Figure 4C). This impairment can also be illustrated by a 
significant shift to the left of the distribution of the myofiber Cross Sectional Area 
(Figure 4D), a decrease in the mean CSA of regenerating myofibers (-42%, p < 
0.0001), (Figure 4D right panel) and an increase in necrotic fiber content (Figure 4E).  
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In addition, when we further followed up the regeneration period in the BMT animals 
we observed that recovery to a morphologically and histochemically mature muscle 
takes at least 2 more weeks (Day 20 post CTX) compared to the non-BMT animals 
(Figure 4F), as shown by the mean CSA of regenerating myofibers (Figure 4G). 
Reducing the radiation dose to 9,5 Gy (sub-lethal dose) and increasing the number of 
BM cells to be injected from 5x106 to 20x106 had only a small effect in improving the 
outcome of regeneration (Figures 4C-E) although bone marrow chimerism did improve 
(Figures 5B-C). Chimerism measurements were performed as shown before (Mocsai A. 
et al., 2002) by using CD45.1 and CD45.2 markers to distinguish between the 
leukocytes, of the donor and that of the recipient. The gating strategy we followed to 
determine the chimerism in the BMT animals is illustrated in Figure 5A.  
Furthermore, we did not find any statistically significant differences between the 
numbers of invading myeloid cells (CD45+) in BMT versus non-BMT controls except 
from Day 4 in which an increase of cell number in the BMT animals was observed 
(Figure 5D), validating our previous results (Figure 3B). Next, we examined the 
dynamics of the infiltrating myeloid cell populations during the course of the 
regeneration in non-BMT controls and BMT animals. At day 1 post CTX injury, the 
predominant cell populations within the muscle are neutrophils and Ly6Chigh 
macrophages (Figure 1B). The ratio of the Ly6Ghigh Ly6Cmed F4/80- neutrophils and the 
Ly6Chigh F4/80low macrophages among the CD45+ cells isolated from injured muscle at 
day 1 was not significantly altered (Figures 5E-F). At day 2 the ratio of Ly6Chigh 
F4/80low (Figure 5F) and Ly6Clow F4/80high (Figure 5G) macrophages in injured 
muscle between BMT and non-BMT controls, was altered (Figures 5E-G). More 
importantly, the difference in the ratio of Ly6Chigh F4/80low and Ly6Clow F4/80high we 
observe at day 2 can be detected all the way through day 6 after the CTX injury 
(Figures 5E-G). In summary, we consistently observe a 2-day delay in the phenotypic 
transition of the infiltrating myeloid cells from inflammatory to the repair phenotype. 
These experiments reported to us, as expected, that irradiation is impacting regeneration 
in the bone marrow transplantation model as well, while we can readily assess the origin 
of the myeloid infiltration.  
In order to maintain the contralateral leg as a control following irradiation and 
BMT, we decided to optimize our radioprotection strategy. Thus, we devised a method 
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to both preserve the satellite cell number and replace the bone marrow derived 
macrophages to be able to assess infiltrating macrophage phenotypic dynamics. 
Methods of radioprotection from radiation-induced toxicity include dose fractionation 
(Figure 4C) and lead shielding (Figure 6A). We measured chimerism at 6, 8, and 12-
week intervals after transplantation and found that chimerism increased with longer 
recovery periods (Figure 6B), higher radiation doses (Figure 6B) and one versus both 
hindlimbs radioprotected (through lead shielding) (Figure 6C). Radioprotecting one leg 
protects/shields the bone marrow; resulting in slightly decreased chimerism (Figure 
6C) but still high enough (>90%) to allow us to assess the contribution of myeloid cell 
infiltration. This observation suggests that the optimization of the leg hindlimb 
radioprotection setup worked without sacrificing chimerism efficiency. Now this 
optimized method allows us (1) to ablate satellite cells, (2) assess muscle regeneration 
outcome, (3) control the origin, and (4) assess the dynamics of myeloid cell infiltration, 
all these in the same animal. In order to simplify the nomenclature, and keeping in mind 
that we are assessing muscles of the same animal, we call BMT-shielded the muscle of 
an animal that underwent irradiation with hindlimb radioprotection (by the usage of lead 
shields) followed by BMT and BMT-unshielded refers to the contralateral muscle of the 
same animal that underwent irradiation (without radioprotection) followed by BMT. In 
a typical experiment we have 3 kinds of muscle, (1) control; meaning muscles from 
non-irradiated, non-shielded, non-BMT animals which reports to us the normal 
regeneration kinetics, (2) BMT-shielded; meaning muscles from irradiated, 
radioprotected and BMT animals, (3) BMT unshielded; meaning muscles from 
irradiated, non-radioprotected and BMT animals. Importantly muscles from group 2 and 
3 come from the same animal. In agreement with our hypothesis, muscle regeneration 
and TA muscle mass at day 8 post CTX injury in unshielded BMT animals was 
significantly impaired compared to contralateral BMT shielded muscles, as illustrated 
by the muscle mass (Figures 6D-E), H&E histology staining (Figures 7B), the 
distribution (Figure 7D) and mean (Figure 7D right panel) myofiber CSA, and 
necrotic fiber content (Figure 7E). The efficiency of the radioprotection can also be 
seen by the preservation of coat colors only in the radiation-protected regions (Figure 
6E left panel). Interestingly, we observed no apparent difference in muscle mass 
(Figure 6D) or CSA (Figures 7A and 7C) of uninjured BMT-shielded versus uninjured 
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BMT-unshielded muscles, and also no central myonuclei in the BMT-unshielded 
muscles suggesting that the radiation does not have a direct long-term effect on muscle 
morphology. Albeit reduced numbers of PAX7 positive cells were observed at 8 weeks 
following irradiation (Figure 2F) it appears that an acute insult to the muscle like CTX, 
is needed to reveal the muscle regeneration deficiency.  
 
Local radioprotection during BMT allows the assessment of donor bone marrow 
derived invading macrophages in an intact muscle tissue environment 
 
The next obvious question was to determine whether radioprotection (lead 
shielding) in the BMT-shielded animals sustains the cellular dynamics of the myeloid 
cell invasion following CTX injury at control levels. Hence, we injected BMT-shielded 
and BMT-unshielded muscles (from the same animal) with CTX and myeloid cells were 
isolated from them at Day 1 to Day 6 after the injury using CD45+ magnetic bead 
selection and Ly6G, Ly6C and F4/80 antibody labeling. Within the same animal the 
contralateral BMT-unshielded muscle showed the two-day delay in the phenotypic 
switch from Ly6Chigh to Ly6Clow (Figures 7F-H), in accordance with the 
histopathological assessment (Figure 7B). To prove that the infiltrating cells in both the 
BMT-shielded and BMT-unshielded muscles originate from the donor C57BL/6J bone 
marrow (CD45.2 positive) and share the same features, we quantified CD45+ positive 
cells according to the myeloid lineage markers CD45.1 (recipient BoyJ bone marrow 
stains positive for CD45.1 but not CD45.2) and CD45.2 by FACS (Figure 8A). Over 
90% of the infiltrating cells in both the BMT-shielded and BMT-unshielded muscles 
were CD45.2 positive which is in line with the level of chimerism detected in the blood 
from the same animals (Figure 8B), thus excluding the contributions of tissue resident 
macrophages in the observed phenotype. By demonstrating that the donor-derived cells 
infiltrate (CD45.1 vs. CD45.2 %) is present, even when the host limb is radioprotected 
during BMT; suggest that this BMT modification could be a viable model for muscle 
regeneration studies despite the tibia and femur not being irradiated. 
Taken together, these results suggest that radioprotection by lead shielding 
effectively attenuated radiation effects and protected muscle tissue integrity. This also 
suggested that the cause of the delay in regeneration is the effect of irradiation of the leg 
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itself and not elsewhere in the body for example in the bone marrow, blood or spleen 
that are sites where myeloid cells could be derived from. 
 
18F-FDG PET-MRI allows in vivo monitoring of the infiltrating immune response 
and reveals that the invading myeloid cells are metabolically distinct. 
 
The analysis of myeloid cells following the injury based on surface markers 
requires long (over 6 hours) and tedious tissue processing. In order to obtain additional 
and truly in vivo non-invasive reading of myeloid cell invasion we turned to in vivo 
imaging. Positron Emission Tomography (PET) imaging technique is a widely used 
noninvasive method in clinical and preclinical studies for the detection of tumors, 
staging and monitoring the effect of cancer therapy (Wester, 2007). Glucose analogue, 
2-[18F] fluoro-2-deoxy-d-glucose (18F-FDG) is the most commonly used and validated 
tracer, which is up taken by activated cells where it is metabolically trapped and 
accumulates in proportion to intracellular demands. Increased FDG uptake was 
observed in several energy-intensive processes, such as infections and inflammation 
(Glaudemans AWJM et al. 2013, Vaidyanathan et al., 2015) and has been associated 
with activated neutrophils and macrophages, so we hypothesized that using FDG as a 
tracer and combining it with MRI (Signore A. 2011, Gondin et al 2015), could be a 
novel and effective method to monitor the events following the acute muscle injury and 
specifically the metabolism of the immune cells during the inflammatory response. 
In order to make sure that muscle metabolism is not interfering with our 
labeling, PET-MRI experiments were always performed during the light cycle in which 
the activity of the mice is minimal and thus muscles considered being at rest. In 
addition, in various exercise physiology studies (Tashiro M, et al. 1999, Kemppainen J, 
et al. 2002, Slimani, L. et al., 2006, Haddock B., et al. 2017) FDG uptake in resting 
muscles is minimal and thus in our experiments Day 0 served as the baseline, allowing 
us to follow the metabolic changes in the muscle, as the result of CTX injury, and 
exclude the contribution of skeletal muscle activity. By the quantitative analysis of the 
decay-corrected 18F-FDG PET images we found significant differences in the mean 
standardized uptake values (SUV) of the indicated TA muscle tissues 50 min after tracer 
injection and at various time points (Day 0-8) post CTX injury (Figure 9A).  
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 The 18F-FDG accumulation in the leg was overall significantly higher in the 
injured TA muscle area in all the timepoints we checked, compared to control uninjured 
animals (mean SUV was 0.21 ±0.01) (Figures 9A and 9C). The 18F-FDG accumulation 
of the gastrocnemius (GAST) muscle area showed very low signal and served as a 
negative control in all timepoints (mean SUV: 0.17 ±0.02). The radiotracer uptake from 
injured muscle region at Day 2 was approximately two-fold higher (0.55 ±0.01) 
compared to all other timepoints followed by Day 1 (0.42 ±0.01) and Day 4 (0.37 
±0.01) post injury (Figure 9C). Next, based on the significantly increased PET signal 
we observed at Day 2 post CTX, we asked whether the signal comes from the muscle 
resident cells or the infiltrating immune cells. To tackle this question, we decided to 
perform an ex vivo 18F-FDG uptake on isolated myeloid CD45+ versus non-myeloid 
CD45- cells from D1 and D2 injured muscles (106 live cells sorted based on FSC/SSC 
gating were used for each group). In accordance with our hypothesis myeloid CD45+ 
cells seem to uptake and utilize almost 5 times more 18F-FDG compared to non-myeloid 
CD45- cells (Figure 9D), which is line with previous observations (Gamelli RL et al. 
1996, Hyafil F et al. 2009, de Prost N et al. 2010), where macrophages co-localize with 
the in vivo PET signal in inflamed tissues. Furthermore, the increased 18F-FDG uptake 
of the myeloid cells (Figure 9D), overlaps with the kinetics of the myeloid cell numbers 
infiltrating the injured muscle (Figure 5F). However one should note that CD45- cell 
fraction might contain a low percentage of dead cells. 
In summary we demonstrated that 18F-FDG PET-MRI is a valuable tool to 
monitor immune cell invasion in vivo.  Thus, we used it in order to delineate and further 
explain the difference in the regeneration process between BMT-shielded and BMT-
unshielded muscles. By the quantitative analysis of the decay-corrected 18F-FDG PET 
images we found significant differences in the mean SUV of the BMT-shielded versus 
BMT-unshielded muscles at various time points (Day 2-6) post CTX injury (Figures 9B 
and 9E) which overlaps with the delayed dynamics of the inflammatory response 
(Figures 7F-H) we observed previously with FACS. More specifically we detected a 
significantly lower accumulation of 18F-FDG in the BMT-unshielded muscles compared 
to the BMT-shielded muscles of the same animal at Day 2, Day 4, Day 5 and Day 6 post 
CTX.  
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In vivo ablation of Pax7+ cells produces similar phenotypic transition delay on 
infiltrating macrophages. 
 
The radioprotection and in vivo imaging experiments presented in this study 
showed that lead shielding during radiation exposure prevented the delay of muscle 
regeneration following CTX injury, preserved the local muscle cell composition and 
sustained infiltrating myeloid cell kinetics and metabolic properties at control levels, 
suggesting that the infiltrating immune response of skeletal muscle regeneration is 
regulated by a local radiosensitive tissue compartment, including PAX7+ satellite cells. 
In order to determine if the decrease in satellite cell numbers observed following 
radiation is contributing to delayed macrophage phenotypic shift, we decided to deplete 
satellite cells in vivo before the injury. By using a transgenic mouse model for selective 
diphtheria toxin-induced depletion of PAX7+ satellite cells (Nishijo K et al. 2009), we 
observed that satellite cell ablation (Pax7 CreER-DTA), leads to a significantly 
decreased muscle mass following the injury (Figures 10A-B). This result is in 
agreement with the current literature in which PAX7 positive satellite cells are 
indispensable for skeletal muscle regeneration both for development (Fry CS et al. 
2015) and following an acute injury (Lepper C., et al 2011, Sambasivan R., et al. 2011). 
Interestingly satellite cell ablation not only led to alterations not only in muscle 
macrophage infiltration numbers both at Day 4 and Day 6 post CTX (Figure 10C) but 
also in dynamic MFs phenotype shift (Figures 10D-G), similar to irradiated and BMT-
unshielded muscles. Therefore our data suggest that it is indeed Pax7-lineage cell pool, 
which is regulating, at least in part, the repair macrophage phenotype transition. 
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Discussion 
 
Tissue regeneration is a complex but precisely coordinated array of processes 
involving cellular recruitment, differentiation, phenotype switches, and intercellular 
communications. We have been interested in defining the role and contribution of 
myeloid cells to pathophysiological processes such as the one during skeletal muscle 
regeneration. In this work, we document that (1) altered cellular composition affects the 
in situ phenotypic transition of invading myeloid cells to repair macrophages, thus (2) 
revealing the existence of reciprocal intercellular communication between satellite cells 
and recruited macrophages during skeletal muscle regeneration, and (3) establish a 
combination of methods to use bone marrow transplantation, with local muscle 
radiation shielding, to identify myeloid cell contribution to tissue repair and monitor the 
myeloid cells metabolic activity in vivo. 
The skeletal muscle microenvironment is very heterogeneous, with distinct cell 
types such as satellite cells, fibroblasts, fibro/adipogenic progenitors (FAPs) adipocytes, 
epithelial cells, Schwann cells, and blood cells, all of which may influence and, in turn, 
be influenced by local structural and biochemical cues (Bentzinger CF. et al. 2013). The 
general consensus holds that satellite cells are required for muscle regeneration. Here 
we show that both, radiation-induced or in vivo ablation (PAX7-DTA) of these cells, 
leads to delayed repair macrophage phenotypic transition and muscle regeneration. 
While there has been several papers demonstrating that infiltrating macrophages 
influence satellite cell behavior (Cantini M et al. 1994, Cantini M et al. 1995, Saclier M 
et al 2013), our data indicate that the reverse is also true, and that Pax7-lineage cells are 
regulating a degree of the in situ macrophage phenotypic shift. However, there are also 
additional cell types that are abundant in healthy muscle, and it’s been recently shown 
that FAPs (Joe AW et. al 2010 , Uezumi A et al. 2010), fibroblasts (Murphy et al 2011), 
endothelial cells (Christov C. et al 2007), and other interstitial cells like pericytes 
(Dellavalle A. et al 2011 Birbrair, A. et al 2014, Kostallari et. al. 2015), expand 
following acute muscle damage, to transiently establish an environment that enhances 
myogenic differentiation. This raises the question whether perturbations of their cellular 
interplay with satellite cells or macrophages could further explain the delay in the 
macrophage phenotype switch. For example, it is known that angiogenesis is crucial for 
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muscle repair and satellite cell survival. In this context endothelial cells strongly 
stimulate myogenic cell growth while myogenic cells promote angiogenesis (reviewed 
in Latroche C et al. 2015). On the other hand, during return to homeostasis, 
periendothelial cells facilitate the return to quiescence of a subset of muscle precursor 
cells that ensures self-renewal of the satellite cell pool (Abou-Khalil R et al. 2010). 
Interestingly, depletion of PAX7+ cells in vivo has no impact on vasculature (CD31+ 
endothelial cells), innervation or neuromuscular junctions (Sambasivan R. et al 2011). 
The same group also documented that FAPs and fibroblasts are unchanged in the 
PAX7+ ablated muscles (Sambasivan R. et al 2011), which suggests that the interaction 
of satellite cells with macrophages is unique and likely to be specific.  
Substantially less is known about the role of the adaptive immune system in the 
regeneration process. Lymphocytes consistently infiltrate the muscle in conditions of 
chronic injury, including muscular dystrophies (Burzyn D et al. 2013, Villalta SA et al. 
2014) and during aging (Kuswanto W et al. 2016). Recent studies have shown that in 
acute injury models, like the CTX model, lymphocytes are recruited and required for the 
healing of the muscle (reviewed in Schiaffino S et al. 2017). More specifically, T 
regulatory cells (Tregs) seem to be involved in muscle repair by directly interacting 
with satellite cells, inducing their expansion (Castiglioni A et al. 2015). It was also been 
shown that Tregs efficiently induced the phenotypic and functional switch to M2 
macrophage differentiation in vivo (Liu G et al. 2011). Thus it will be interesting for 
future studies to explore possible interactions of Tregs with satellite cells and 
macrophages in our system, which could potentially influence the phenotypic shift of 
the muscle infiltrating macrophages.  
Our findings that PAX7 positive satellite cells affect macrophage phenotypic 
transition poses several more questions, regarding a potential niche for macrophages 
formed by satellite cells, what signaling molecules/cytokines influence the 
communication between these cell types and whether satellite cells produce signals that 
instruct macrophage functions such debris clearance, phagocytosis and myogenesis. It 
will require selective depletion or replenishment of satellite cells and other cell types to 
establish the cause and effect relationships between them and macrophage invasion, 
phenotypic switching and contribution to repair. Future studies should test whether 
radiation causes a depletion of these and other local interstitial cells with myogenic 
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potential that could affect also the cross talk with the immune cells following acute 
damage, which in turn can affect macrophage infiltration and phenotypic dynamics, and 
subsequently muscle regeneration outcome.  
In order to understand these complex interactions one needs more complex 
methodologies. We believe that our work here goes to some distance to address these 
needs. Cardiotoxin injection in TA muscles is very well suited to study immune cell 
infiltration because it induces extensive, homogenous and synchronous damage. 
Myeloid cells are invading the injured muscle, and during the course of regeneration, 
dynamically alter their phenotype by day 4 in a highly ordered and reproducible 
manner, leading to complete regeneration (ad integrum) of the muscle fibers by day 8. 
A recent study (Wang et al. 2014) provides mechanistic insights into the contribution of 
monocyte-derived subsets by eliminating CD11b+ monocyte and macrophage subsets 
using a diphtheria toxin inducible system and the CTX injury model. They were able to 
show by transient and differential ablation that not only monocyte-derived 
macrophages, but also the phenotypic transition is necessary for proper regeneration. In 
this context our data suggest that the delayed transition is likely to be causative of 
impaired regeneration. 
Several important signaling pathways and transcriptional regulators such as 
IGF-1, CEBPb, AMPK, P-38 (Tonkin J et al. 2015, Ruffell D et al. 2009, Mounier et al. 
2013, Perdiguero E et al. 2011) have been implicated in the phenotypic transition of 
these muscle macrophages (from the pro-inflammatory/phagocytic phenotype 
(Ly6Chigh) to the anti-inflammatory/reparatory phenotype (Ly6Clow)) using the CTX 
model. However, many more pathways could be implicated (reviewed in Lawrence T. 
and Natoli G 2011) and further work towards their identification is needed. To this end, 
loss of function experiments have been employed to identify key genes, by crossing 
gene specific floxed allele containing mice with the myeloid-specific LysM-CRE strain 
(Clausen et al. 1999), in order to generate myeloid-specific knock out strains. However, 
the availability of conditional myeloid specific knockout mice for most genes is a 
limiting factor in delineating their role in the macrophage phenotype switch during 
muscle injury and regeneration. A commonly used method to assess the contribution of 
myeloid cell populations in in vivo murine disease models is bone marrow 
transplantation (BMT). During this CD45 congenic method, the bone marrow of 
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animals is eliminated by total body irradiation and then reconstituted by injecting a 
fresh bone marrow isolated from specific donor animals that are usually genetically 
manipulated. The fact that the congenic donor cells can be easily tracked is also highly 
beneficial. However, the requirement for total body irradiation leads to unwanted 
inflammation, tissue injuries and fibrosis (Colson et al., 1996; Johnston et al., 2002; 
Ghosh et al., 2009) if not properly optimized. Despite the fact that it has been 
previously reported that muscle regeneration is impaired in irradiated muscles (Gulati 
AK 1987, Wakeford et al. 1991), BMT experiments to generate chimeric mice have 
been used extensively as an alternative tool in muscle regeneration studies (Mounier et 
al 2013, Perdiguero et al 2011). Therefore, we reasoned that the combination of an 
optimized BMT method with dose fractionation and in vivo imaging would allow us to 
trace and characterize myeloid cell invasion and cellular interactions and overcome the 
radiation effect. Low radiation doses lead to incomplete engraftment due to survival of 
the host bone marrow (Soderling et al., 1985; Colson et al., 1996; Baskiewicz-Masiuk et 
al., 2009) but at the same time can also lead to macrophage activation (Finkelstein et al., 
1994; Lorimore et al., 2001; Coates et al., 2008). Thus, an optimum radiation dose is 
needed to achieve complete BM ablation without causing any local organ damage. 
According to the current literature irradiation doses of 7 to 13 Gy are myeloablative but 
one needs to be aware that the higher the dose, the higher the risk for the animals to die 
from irradiation-induced toxicity (Down JD et al. 1991, Hardee, J. P et al 2014). As 
mentioned above methods for reducing radiation toxicity include dose fractionation (in 
which smaller doses of radiation are administered sequentially) and lead shielding. The 
latter method was successfully used by Labar et al and Murphy et al. to protect the lungs 
and study alveolar macrophage turnover following BMT, but were limited by high 
levels of mixed chimerism in the circulation due to head and forelimbs being lead 
shielded as well (Labar et al. 1992, Murphy et al. 2008).  
In our study and in order to bypass these limitations, (1) we used radioprotection 
sparingly, focused on protecting only one hindlimb (to minimize radioprotection of the 
recipient animal’s BM), (2) increase the number of transplanted cells to 20x106 
cells/BMT animal in order to increase the degree of chimerism in favor of donor BM 
repopulation (hindlimb radioprotection increases survival of host BM that in turn 
increases the competition with the donor BM), and (3) increase recovery time to 12 
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weeks post BMT, thus allowing us, both to reach high levels of blood chimerism 
(>90%) and protect the local radiosensitive muscle compartments (e.g. satellite cell 
pool).  
Our combined method with in vivo tracing of myeloid cells by PET-MRI is an 
important advance allowing real time assessment of cell invasion as opposed to cell 
sorting that requires several hours of processing. These findings have general 
ramifications because it may be possible to extend the utility of this system to other 
organs, for studies that require preservation of resident cell populations in bone marrow 
transplanted animals, and especially in cases of immune cell invasion. In addition, this 
method allowed us to examine, monitor and characterize the immune cell invasion 
following acute injury by CTX. The PET-MRI in vivo imaging studies showed that 
these invading cells seem to have special metabolic properties biased towards 
glycolysis. In support of this observation, Mounier et al 2013 showed that M2a 
macrophages had an increased basal and maximal oxygen consumption rate (OCR) in 
comparison to M1 and M2c macrophages which could further explain the increased 
SUV signal at Day 2 following the injury. Our findings suggest that 18F-FDG PET-MRI 
is a useful tool to monitor immune cell invasion and to help to delineate and further 
explain the difference in the regeneration process in the irradiated muscles and 
especially the difference between BMT-shielded and BMT-unshielded muscles. Further 
acute sterile injury models in other tissues, such as liver or skin injury, could validate 
our PET-MRI results. 
In conclusion, our work has translational implications on the muscle 
regenerative potential of the elderly following radiation therapy. Our findings suggest 
that irradiation of skeletal muscle might impair the ability of satellite cells to orchestrate 
macrophage phenotypic transition further impacting regeneration potential. This is in 
addition to other known side effects of irradiation such as direct effects on myoblasts 
(Jurdana et al. 2013). Our findings also convey potential ramifications for pathological 
circumstances in which recurrent muscle damage and satellite cell mediated 
regeneration asynchrony leads to devastating muscle diseases, such as Duchenne 
Muscular Dystrophy, which are most of the time associated with the permanent 
presence (and potential interaction) of inflammatory cells, especially macrophages. 
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Limitations 
 
There are some technical limitations of this work. By using this modified BMT 
method in studies to assess myeloid contribution in muscle regeneration, the sample 
size might be too small (using only the shielded leg) and thus it could be difficult to find 
significant relationships among the data, due to the fact that statistical tests for such 
quantitative (i.e. CSA) studies will require a larger sample size. This will lead to 
doubling the number of animals in order to ensure a representative distribution of 
myofiber size and to reliably conclude as to the outcome of regeneration. Furthermore, 
the increase in cell numbers to be transplanted from 5x106 to 20x106 will also increase 
the number of donor BM animals. Another limitation of our study is the usage of a 
human cobalt radiation source (gamma rays being used). Since various radiation sources 
(some are exclusively build for small animal research use) and types exist, such as 
gamma rays, and X-rays (lower energy and longer wavelength compared to gamma 
rays), with the latter being the most frequently used in radiation and BMT research, one 
cannot exclude the possibility of slightly different satellite cell ablation, chimerism and 
shielding efficiency depending on the aforementioned parameters. In addition, the 
radiation dose we chose and optimize was specific for the C57BL/6J strain. However 
one needs to keep in mind that different inbred strains can tolerate different radiation 
doses (Duran-Struuck R et al. 2008). Thus minor dose and shielding optimization will 
be needed to attain comparable results. Finally, a conceptual limitation is that the 
contribution of other cell types to the observed phenotype cannot be excluded with 
absolute certainty. 
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Figure Legends 
 
Figure 1. Cardiotoxin induced injury model and dynamic phenotype shift of 
muscle infiltrating macrophages.  
 
A. Tibialis anterior muscles from C57BL/6J mice were injected with CTX and were 
recovered at various days after injury. Representative H&E stained muscle are 
shown. Scale bars represent 100µm. 
B. CD45+ cells isolated from regenerating muscle according to their Ly6C, Ly6G and 
F4/80 expression. Red circles labels inflammatory (Ly6Chigh F4/80low) and black 
circles label repair (Ly6Clow F4/80high).  
C. FACS gating strategy to enumerate muscle infiltrative macrophages at day 1 and 4 
post CTX injury. CD45+ cells were gated for a FSC/SSC pattern consistent with 
monocytic cells, and then percentage of Ly6Chigh F4/80low and Ly6Clow F4/80high MF 
subsets of all FSC/SSC-gated cells was calculated. 
D. Immunofluorescence images of regenerating tibialis anterior muscle from a 9-wk-
old wild-type mouse at Day 4 and Day 8 after cardiotoxin-induced injury. The tissue 
was stained with antibodies directed against the macrophage marker F4/80 (green), 
the intermediate filament protein desmin (red) and with DAPI (blue) to visualize the 
cell nuclei. Scale bars represent 100µm. 
E. Heatmap representation of the expression pattern of pro-inﬂammatory and anti-
inﬂammatory markers by muscle derived Ly6Chigh and Ly6Clow macrophages at day 
1, 2 and 4 post CTX injury (GEO: GSE71155). Hierarchical clustering was 
performed to ﬁnd correlate genes.  
 
Figure 2. Diminished satellite cell numbers in radiation-exposed muscles impairs 
skeletal muscle regeneration. 
 
A. Representative images of H&E stained TA muscles from 11Gy irradiated and 
radioprotected muscles at day 8 post CTX induced injury. Scale bars represent 
100µm. 
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B. Myofiber cross sectional area repartition (cumulated) and mean CSA (right 
panel) in control non-irradiated, irradiated and radioprotected animals at day 8 
post CTX injury (n=8 per group).  
C. The ratio of phagocytic and/or necrotic fiber area relative to the regeneration 
area (in mm2) at day 8 post CTX injury in control non-irradiated, irradiated and 
radioprotected muscle sections are shown (n=8 per group). 
D. mRNA expression (±SD) of satellite cell lineage marker, Pax7 in control non-
radiated, irradiated and radioprotected muscles at Day 0 (uninjured) and Day 8 
post CTX injury (n=5 for each group).  
E. Representative images from IHC detection of lamimin (red), PAX7 (green) and 
nuclei (blue) from control non-radiated, irradiated and radioprotected muscles at 
day 0 (upper panel) and day 8 (lower panel) post CTX injury. Scale bars 
represent 50µm. 
F. PAX7+ cell quantification (PAX7 positive cells per field of view) in control non-
radiated, irradiated and radioprotected muscles at day 0 post CTX injury. 
G. PAX7+ cell quantification (PAX7 positive cells per field of view) in control non-
radiated, irradiated and radioprotected muscles at day 8 post CTX injury. 
In all graphs, mean values ± SEM are shown.  
 
Figure 3.  Delayed phenotypic transition of infiltrating myeloid cells in irradiated 
animals following CTX injury. 
 
A. Normalized TA muscle weight to body weight ratio from control non-irradiated 
and WBS animals at indicated timepoints following CTX injury (n=4 per 
group).  Left panel shows representative macroscopical images of recovered 
WBS animals and muscles at day 8 post CTX injury.  
B. Number of infiltrating myeloid (CD45+) cells in regenerating muscle from 
control non-irradiated, irradiated and radioprotected muscles at day 4 and 6 post 
CTX injury (n = 8 muscles per group).  
C. Representative FACS images of inflammatory and repair macrophages from 
control non-irradiated, irradiated and radioprotected muscles at day 4 and 6 post 
CTX injury.  
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D. Percentage of inflammatory (Ly6Chigh F4/80low) and repair (Ly6Clow F4/80high) 
MFs from control non-irradiated, irradiated and radioprotected muscles at day 4 
following CTX injury, respectively (n = 8 mice per group). 
E. Percentage of inflammatory (Ly6Chigh F4/80low) and repair (Ly6Clow F4/80high) 
MFs from control non-irradiated, irradiated and radioprotected muscles at day 6 
following CTX injury, respectively (n = 8 mice per group). 
In all graphs, mean values ± SEM are shown.  
 
Figure 4. Impaired regeneration of skeletal muscle in bone marrow transplanted 
animals. 
 
A. Normalized TA muscle to body weight from aged and weight matched control 
non-BMT and bone marrow transplanted (BMT) animals at indicated timepoints 
following CTX injury. By day 8 post CTX TA muscle weight drops from 
0.056gr to 0.046gr in the control non-BMT animals and from 0.053gr to 0.025gr 
in the BMT animals.  
B. Representative macroscopical image of TA muscle from control (left) and BMT 
(right) animals at day 8 post CTX injury. 
C. Representative images of H&E stained muscle from control (non-BMT) and 
BMT animals radiated with 11 or 9,5 Gy at day 8 post CTX induced injury. 
Asterisks label phagocytic and/or necrotic fibers. Scale bars represent 100µm. 
D. Myofiber cross sectional area repartition (cumulated) and mean CSA (right 
panel) in control and BMT animals (radiated with 11 or 9,5 Gy) at day 8 post 
CTX injury (number of fibers counted > 20000). Significance is shown for 
control vs. BMT 11Gy. 
E. The ratio of phagocytic and/or necrotic fiber area relative to the regeneration 
area at day 8 in control and BMT muscle sections are shown. 
F. Representative images of H&E stained muscle from control (non-BMT) and 
BMT animals at the indicated timepoints post CTX injury. 
G. Average fiber cross sectional area (CSA) of regenerating muscle at indicated 
timepoints post CTX injury in control and BMT animals. All data timepoints 
were compared to day 8 controls.  n = (numbers of individual muscles, derived 
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from controls or BMT animals): at least 8 muscles for each sample per 
timepoint.  
In all graphs, mean values ± SEM are shown.  
 
Figure 5. Delayed phenotypic transition of infiltrating myeloid cells in BMT 
animals following CTX injury.  
 
A. FACS gating strategy to calculate chimerism levels following BMT. The ratio of 
donor (CD45.2+) to host (CD45.1+) bone marrow repopulation is gated on the 
granulocyte fraction using CD45.2 and GR1 antibodies. 
B. Percentage of chimerism in BMT animals receiving different radiation doses (one 
single dose of 11 Gy or 9.5Gy and 2 consecutive doses of 5 Gy with a 24h rest 
period between them). 
C. Percentage of chimerism in BMT animals injected with different numbers of donor 
cells (5, 10, 20 and 50 x 106 cells). In both chimerism experiments n>8 per group. 
D. Number of infiltrating myeloid (CD45+) cells in regenerating muscle at day 1,2 and 
4 post CTX injury (n = 8 muscles per group).  
E. FACS gating strategy to enumerate muscle infiltrative Ly6Chigh F4/80low and 
Ly6Clow F4/80high macrophages at day 1 - 6 post CTX injury. Upper panel (blue) 
shows representative samples from control animals and lower (red) from BMT 
animals.  
F. Percentage of Ly6Chigh F4/80low muscle MFs at indicated timepoints following CTX 
injury (n = 12 mice per group) in control non-BMT and BMT samples. Day 2 – Day 
6 comparisons between groups give statistically significant results (** p-value < 
0.01). 
G. Percentage of Ly6Clow F4/80high muscle MFs at indicated timepoints following CTX 
injury (n = 12 mice per group) in control non-BMT and BMT samples. Day 2 – Day 
6 comparisons between groups give statistically significant results (** p-value < 
0.01). 
In all graphs, mean values ± SEM are shown.  
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Figure 6. BMT with radioprotection optimized setup. 
 
A. Representative images of the shielding adaptation during irradiation. The mice were 
put into a plastic box, with double wall and water was used for scattering medium. 
Two 5 cm high led blocks on the PMMA shadow tray were used for protection one 
of the legs (red circles) of the mouse at 20 cm distance to the surface of the plastic 
box. The source surface distance (SSD) and source axis distance (SAD) was 80 cm. 
The beam size is 21x21 cm. Illustration model uses a modified version of art from 
Servier Medical Art under a Creative Commons (CC) license. 
B. Percentage of chimerism in animals left to recover for 6 vs. 12 weeks post 
irradiation and BMT (n=8 per group). 
C. Percentage of chimerism in BMT animals with one vs. both legs shielded (n=8 per 
group). 
D. Normalized TA muscle to body weight ratio from BMT shielded vs. unshielded 
animals at indicated timepoints following CTX injury (n=16 per group). 
E. Representative macroscopical images of recovered BMT shielded animals (left) and 
muscles at day 8 post CTX (right). The fur color was preserved in the shielded leg 
(red circle) but not in the unshielded leg (blue cirlce) of the same animal.  
In all graphs, mean values ± SEM are shown.  
 
Figure 7. Radioprotected muscles during BMT have normal recovery time 
following CTX injury. 
 
A. Representative images of H&E stained uninjured TA muscles from control non-
BMT, BMT-shielded and BMT-unshielded muscles. Scale bars represent 100µm. 
B. Representative images of H&E stained TA muscle from control non-BMT, 
BMT-shielded and BMT-unshielded muscles radiated with 11 or 9,5 Gy at day 8 
post CTX induced injury. Scale bars represent 100µm. 
C. Average fiber cross sectional area (CSA) of uninjured (Day 0) TA muscle from 
control non-BMT, BMT-shielded and BMT-unshielded muscles (n = 12 muscles 
per group).  
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D. Myofiber cross sectional area repartition (cumulated) and mean CSA (right 
panel) in control non-BMT, BMT-shielded and BMT-unshielded muscles (n = 12 
muscles per group) at day 8 post CTX (number of fibers counted > 20000).  
E. The ratio of phagocytic and/or necrotic fiber area relative to the regeneration 
area at day 8 in control non-BMT, BMT-shielded and BMT-unshielded muscle 
sections are shown.  
F. FACS gating strategy to enumerate muscle infiltrative Ly6Chigh F4/80low and 
Ly6Clow F4/80high macrophages at day 1 - 6 post CTX injury. Upper panel (blue) 
shows representative samples from control non-BMT animals; middle panel 
(green) shows samples from BMT-shielded muscles and lower panel (red) from 
BMT-unshielded muscles.  
G. Percentage of Ly6Chigh F4/80low muscle MFs from control non-BMT, BMT- 
shielded and BMT-unshielded animals at indicated timepoints following CTX 
injury (n = 12 mice per group). 
H. Percentage of Ly6Clow F4/80high muscle MFs from control non-BMT, BMT-
shielded and BMT-unshielded animals at indicated timepoints following CTX 
injury (n = 12 mice per group).  
In all graphs, mean values ± SEM are shown. 
 
Figure 8. Infiltrating cells in both the BMT-shielded and BMT-unshielded muscles 
share the same features and originate from the donor C57BL/6J bone marrow. 
 
A. Muscle macrophages origin tracing based on the myeloid lineage markers CD45.1 
(host BoyJ bone marrow stains positive for CD45.1 but not CD45.2) and CD45.2 
(donor bone marrow stains positive for CD45.2 but not CD45.1) at day 1 post CTX 
injury. Both the BMT-shielded and BMT-unshielded muscles were over 90% 
CD45.2 positive (n=4 per group). 
B. Blood chimerism levels from the same BMT animals prior to the above terminal 
experiment (n=4 per group). 
 
 
52		
Figure 9. In vivo monitoring of the infiltrating immune response with 18F-FDG 
PET-MRI. 
 
A. Representative whole body PET-MRI images (axial, coronal and sagittal planes are 
shown) of control non-BMT at indicated timepoints post CTX injury. Images were 
obtained 50 mins after i.v. injection with 8.0±0.2 MBq 18F-FDG. Arrows show 
muscles under consideration (white arrows indicate Tibialis anterior and yellow 
arrows indicate Gastrocnemius). Corresponding video images are included in 
Supplementary material. 
B. Representative whole body PET-MRI images (axial, coronal and sagittal planes are 
shown) of BMT mice with right leg radioprotection (lower panel) at indicated 
timepoints post CTX injury. Images were obtained 50 mins after i.v. injection with 
8.0±0.2 MBq 18F-FDG. Arrows show muscles under consideration (white arrows 
indicate TA and yellow arrows indicate GAST). Corresponding video images are 
included in Supplementary material. 
C. Quantitative analysis of the 18F-FDG uptake of the injured TA muscles in control 
non-BMT at indicated timepoints post CTX injury. 18F-FDG-Standardized Uptake 
Value (SUV) mean of TA and GAST (used as baseline muscle SUV mean) muscles 
are shown (n=8).  
D. Ex vivo 18F-FDG uptake (shown as incubation dose % per 106 live cells) of the 
myeloid CD45+ versus non-myeloid CD45- cell fractions (106 live cells were sorted 
in each group/experiment) of the injured TA muscles in control non-BMT at 
indicated timepoints post CTX injury (n=4).  
E. 18F-FDG-Standardized Uptake Value (SUV) mean of injured TA and uninjured 
GAST muscles from BMT-shielded versus BMT-unshielded muscles of the same 
animal at indicated timepoints are shown (n=8).  
In all graphs, mean values ± SEM are shown.  
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Figure 10.  Delayed phenotypic transition of infiltrating myeloid cells in satellite 
cell depleted animals following CTX injury. 
 
A. Representative macroscopical image of TA muscles from control (left) and satellite 
cell ablated PAX7ER – DTA (right) animals at day 4 and 6 post CTX injury. 
B. TA muscle weight from control versus PAX7ER – DTA animals at indicated 
timepoints following CTX injury (n=4 per group).   
C. Number of infiltrating myeloid (CD45+) cells in regenerating muscle of satellite cell 
depleted animals (PAX7ER – DTA), at day 2, 4 and 6 post CTX injury (n = 16 
muscles per group).  
D. Percentage of inflammatory (Ly6Chigh F4/80low) and repair (Ly6Clow F4/80high) 
muscle MFs from control and PAX7ER – DTA animals at day 2 following CTX 
injury, respectively (n = 12 mice per group). 
E. Percentage of inflammatory (Ly6Chigh F4/80low) and repair (Ly6Clow F4/80high) 
muscle MFs from control and PAX7ER – DTA animals at day 4 following CTX 
injury, respectively (n = 12 mice per group). 
F. Percentage of inflammatory (Ly6Chigh F4/80low) and repair (Ly6Clow F4/80high) 
muscle MFs from control and PAX7ER – DTA animals at day 6 following CTX 
injury, respectively (n = 12 mice per group). 
G. Representative FACS images of Ly6Chigh F4/80low and Ly6Clow F4/80high 
macrophages at day 2, 4 and 6 post CTX injury. Upper panel shows representative 
samples from control animals while lower panel from PAX7ER – DTA animals.  
In all graphs, mean values ± SEM are shown.  
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